IT1238210B - Cefamandol naftate esters, preparation procedure and relative pharmaceutical compositions. - Google Patents

Cefamandol naftate esters, preparation procedure and relative pharmaceutical compositions.

Info

Publication number
IT1238210B
IT1238210B IT02205589A IT2205589A IT1238210B IT 1238210 B IT1238210 B IT 1238210B IT 02205589 A IT02205589 A IT 02205589A IT 2205589 A IT2205589 A IT 2205589A IT 1238210 B IT1238210 B IT 1238210B
Authority
IT
Italy
Prior art keywords
esters
naftate
cefamandol
pharmaceutical compositions
preparation procedure
Prior art date
Application number
IT02205589A
Other languages
Italian (it)
Other versions
IT8922055A0 (en
IT8922055A1 (en
Inventor
Laura Puricelli
Original Assignee
Magis Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magis Farmaceutici filed Critical Magis Farmaceutici
Priority to IT02205589A priority Critical patent/IT1238210B/en
Publication of IT8922055A0 publication Critical patent/IT8922055A0/en
Publication of IT8922055A1 publication Critical patent/IT8922055A1/en
Application granted granted Critical
Publication of IT1238210B publication Critical patent/IT1238210B/en

Links

Landscapes

  • Cephalosporin Compounds (AREA)

Abstract

This describes the esters of acid 7-(D-2-formyloxy-2-phenyl-acetamide)-3-(1-methyl-1-H-tetrazole-5-yl)-thiomethyl-3-cephem-4-carboxylic with alkoxy -2-propanol in optically active or racemic form, which, when utilized in bacterial disease therapy, are absorbed by mouth in notably superior quantities respect to the acid administered in the same way.
IT02205589A 1989-10-18 1989-10-18 Cefamandol naftate esters, preparation procedure and relative pharmaceutical compositions. IT1238210B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT02205589A IT1238210B (en) 1989-10-18 1989-10-18 Cefamandol naftate esters, preparation procedure and relative pharmaceutical compositions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02205589A IT1238210B (en) 1989-10-18 1989-10-18 Cefamandol naftate esters, preparation procedure and relative pharmaceutical compositions.

Publications (3)

Publication Number Publication Date
IT8922055A0 IT8922055A0 (en) 1989-10-18
IT8922055A1 IT8922055A1 (en) 1991-04-18
IT1238210B true IT1238210B (en) 1993-07-12

Family

ID=11190804

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02205589A IT1238210B (en) 1989-10-18 1989-10-18 Cefamandol naftate esters, preparation procedure and relative pharmaceutical compositions.

Country Status (1)

Country Link
IT (1) IT1238210B (en)

Also Published As

Publication number Publication date
IT8922055A0 (en) 1989-10-18
IT8922055A1 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
ATE76747T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LEVODOPA METHYL ESTER, THEIR PREPARATION AND THERAPEUTIC USES.
GR3007202T3 (en)
PH23248A (en) Process for the preparation of quinolone-carboxylic acid
DK642587A (en) INSULIN PREPARATION
CA2123049A1 (en) Pharmaceutical containing the p40 subunit of interleukin 12
IE882091L (en) Pharmaceutical compositions comprising sometostatin¹analogues
IT8322855A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE.
ES2160643T3 (en) COMPOSITIONS CONTAINING G-CSF AND PROTEIN OF UNION TO TNF.
SE7902742L (en) DISUBSTITUTED 3-CEFEM-4-CARBOXYLIC ACID DERIVATIVES AND PROCEDURES FOR THE PREPARATION
NO810480L (en) ANOLOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3,4-OCSADIAZOLYLPHENOL DERIVATIVES
ES2044170T3 (en) STRONTIUM SALT, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
IT1238210B (en) Cefamandol naftate esters, preparation procedure and relative pharmaceutical compositions.
AU1200488A (en) Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
ATE2746T1 (en) PIPERIDINE DERIVATIVES OF 4,5-DIALKYL-3-HYDROXYPYRROL-2-CARBONS[UREESTERS, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
EP0256385A3 (en) Use of 15-deoxyspergualine as a medicament
ATE4808T1 (en) PIPERIDINE DERIVATIVES OF 3-HYDROXY-THIOPHEN-2CARBONS[UREESTERS, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
KR880008812A (en) Antibacterial freeze-dried preparation
ATE12649T1 (en) OPTICALLY ACTIVE DIPEPTIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
SE8802323D0 (en) 8ALFA-ACYLAMINOERGOLINE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
FR2645747B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS, THEIR PROCESS FOR OBTAINING AND THEIR USE IN TUMOR THERAPEUTICS
IT1246050B (en) USE OF HEPTASTIGMIN IN CEREBRAL STROKE THERAPY.
IT1251993B (en) Pharmaceutical compositions for oral use based on internal ganglioside esters for the treatment of neural diseases of the peripheral nervous system
FR2592793A1 (en) Combination of sulpiride and diazepam as a pharmaceutical composition which is useful, in particular, in the treatment of stress-linked functional digestive manifestations, and its use for the preparation of the aforementioned composition
IT1142260B (en) L-ALANINE AS A PHARMACEUTICAL AGENT USED FOR THE TREATMENT OF VASCULAR CEREBROPATHIES AND RELATED FORMULATIONS

Legal Events

Date Code Title Description
0001 Granted